| Financial Year |
March 31 2023 |
| Monetary Funds |
7,557,780,990.44 |
| Held-for-trading Financial Assets |
2,252,952,251.74 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,455,720,355.76 |
| Advances to Suppliers |
722,028,469.74 |
| Other Receivables |
78,693,095.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
196,712,257.40 |
| Other Current Assets |
49,357,472.57 |
| Total Current Assets |
12,313,244,893.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
614,872,058.28 |
| Investment Properties |
-- |
| Fixed Assetes |
839,913,551.81 |
| Under-construction Projects |
263,485,568.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,051,026,165.33 |
| R&D expenses |
-- |
| Goodwill |
1,589,065,048.53 |
| Long-Term Deferred and Prepaid Expenses |
111,945,626.67 |
| Deferred Income Tax Assets |
38,404,370.83 |
| Other Non-Current Assets |
1,213,471,823.52 |
| Sub-Total of Non-Current Assets |
6,714,472,463.30 |
| Total Assets |
19,027,717,356.73 |
| Short-Term Loans |
1,453,001,825.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,082,000,000.00 |
| Accounts Payable |
1,749,815,642.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
177,941,095.04 |
| Taxes Payable |
265,736,525.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
214,887,052.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
52,894,136.12 |
| Other Current Liabilities |
53,050,174.05 |
| Sub-Total of Current Liabilities |
5,299,498,393.56 |
| Long-term Loans |
503,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
102,407,090.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
622,399,955.54 |
| Total Liabilities |
5,921,898,349.10 |
| Paid-In Capital(Or Share Stock) |
2,217,864,281.00 |
| Capital Surplus |
2,814,513,291.09 |
| Surplus Reserve |
666,869,940.33 |
| LESS:Treasury Stock |
83,105,950.55 |
| Undistributed Profits |
7,533,401,697.26 |
| Minority Stockholder's Interest |
120,523,726.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,985,295,281.01 |
| Owner's Equity（Stockholder's Equity） |
13,105,819,007.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,027,717,356.73 |
